You are here

Biologically-Derived Targeted Antimicrobials for Textile Applications

Award Information
Agency: Department of Defense
Branch: Army
Contract: W911NF-14-P-0015
Agency Tracking Number: A14A-012-0127
Amount: $149,950.00
Phase: Phase I
Program: STTR
Solicitation Topic Code: A14A-T012
Solicitation Number: 2014.A
Timeline
Solicitation Year: 2014
Award Year: 2014
Award Start Date (Proposal Award Date): 2014-08-11
Award End Date (Contract End Date): 2015-02-10
Small Business Information
2200 Kraft Drive Suite 2475
Blacksburg, VA -
United States
DUNS: 006339672
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 Joshua Bryson
 Chief Scientific Officer
 (540) 443-9253
 josh.bryson@techulon.com
Business Contact
 Brett Malone
Title: President
Phone: (540) 443-9253
Email: brett.malone@techulon.com
Research Institution
 Virginia Tech
 John Rudd
 
300 Turner Street, Suite 4200
Blacksburg, VA 24061-
United States

 (540) 231-5281
 Nonprofit College or University
Abstract

Skin infections caused by bacteria represent a significant risk to wounded soldiers. The most common source of bacterial infection is found in the fabrics of clothing, boots, and gear worn by the warfighter. Reducing the risk of infection for soldiers by treating the source fabrics will lead to positive outcome and support medically-related activities in non-sterile environments encountered by the war fighter. The objectives of this proposal are aimed at developing biologically-derived antimicrobials that inhibit the primary bacteria responsible for skin-related infections and/or odor, while maintaining the viability of bacteria that make up the microbiome, which is highly diverse and tantamount to minimizing opportunistic infections. Objectives are tailored to develop robust technology that selectively kills Corynebacteria, which is primarily responsible for malodor associated with sweat and Staphylococcus aureus, which is associated with a variety of skin and skin structure infections (S & SI). The important benefit of the technology being proposed is that it will not destroy bacteria required for a healthy skin microbiome. Targets are discovered with informatics, tested in culture, and tested for safety to both the skin microbiome and healthy skin cells. Establishing selective antibacterial textiles will show great prophylactic decrease the prevalence of S & SI related ailments.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government